Hangzhou Chengyuan Genomics will provide single-cell analysis services and sell 1CellBio's InDrop instrument, reagents, and kits in China.
The system uses microfluidics and real-time image analysis to isolate single cells and provide visual documentation of monoclonality.
The device allows researchers to track cancer growth for a longer period of time, enabling improved observations and analysis, according to the researchers.
Ascendas will develop and commercialize molecular diagnostic systems and assays using certain of Fluidigm's microfluidic technologies.
New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.
The Bay Area firm is planning to launch a low-cost, microfluidics-based infectious disease diagnostic called the Simple Chip in the next few years.
The company is providing several of its Parsortix instruments to the CANCER-ID consortium as part of an effort to establish liquid biopsy in routine clinical practice.
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
The agency is sending an Oxford Nanopore MinIon to the International Space Station to determine if the technology's microfluidic system can work in microgravity.
The aim of the project, called Metafluidics, is to replace cumbersome conventional approaches with a cheaper, faster, and higher-throughput microfluidics platform.
Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.
The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.
In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.
Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.